Novo Nordisk announced Monday that in two closely watched studies, an oral version of semaglutide — the active ingredient in weight loss drugs — failed to help slow the progression of Alzheimer’s.

Molecular profiles of oligodendrocytes and microglia in rhesus monkeys that followed a lifelong 30% calorie restriction diet ...

Evaluation of Concentrations and Dispersion of Heavy Metals in Soils Surrounding Artisanal and Small-Scale Gold Mining in ...